previous compound ID: 791 next compound
InChIKey: HAPOVYFOVVWLRS-UHFFFAOYSA-N
SMILES: CCC1(CC(=O)NC1=O)C

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"E Matthes" "R Robert" "D Rotin" "JW Hanrahan" "B Kus" "J Goepp" "DY Thomas" "J Liao" "GW Carlile" "SD Macknight"

chemical graph of compound 791





CID is 3291
synonyms found at PubChem are:
ethosuximide, Zarontin, 77-67-8, Etosuximida, 2-Ethyl-2-methylsuccinimide, Ethosuxide, Ethosuccimide, Ethosuccinimide, Petnidan, Suxinutin, Atysmal, Emeside, Ethymal, Suxilep, Etosuximid, Pentinimid, Peptinimid, Petinimid, Pyknolepsinum, Succimitin, Zaraondan, Capitus, Mesentol, Pemalin, Simatin, Succimal, Suximal, Thetamid, Zarodan, Zarondan, Zartalin, Asamid, Etomal, Pemal, Ronton, Suxin, Aethosuximide, Piknolepsin, Thilopemal, Epileo Petit MAL, 3-Ethyl-3-methylpyrrolidine-2,5-dione, Zarondan-Saft, Ethosuximidum, Simatin(E), 3-Methyl-3-ethylsuccinimide, Aethosuccimidum, Etosuximide, CI-366, 2,5-Pyrrolidinedione, 3-ethyl-3-methyl-, Succinimide, 2-ethyl-2-methyl-, 2-Methyl-2-ethylsuccinimide, Ethosuccimid, Etosuccimide, PM 671, PM-671, Suksilep, Etosuccimide [DCIT], 3-Ethyl-3-methyl-2,5-pyrrolidinedione, 3-Ethyl-3-methylsuccinimide, Aethosuximide [German], CN-10,395, N-Ethyl methylsuccinimide, Ethylmethylsuccimide, 3-Methyl-3-ethylpyrrolidine-2,5-dione, Ethosuximidum [INN-Latin], Etosuximida [INN-Spanish], alpha-Ethyl-alpha-methylsuccinimide, alpha-Methyl-alpha-ethylsuccinimide, C.I. 366, gamma-Methyl-gamma-ethyl-succinimide, H 940, H-490, Cl 366, Pyknole.psi.num, Piknole.psi.n, (+-)-2-Ethyl-2-methylsuccinimide, Zarontin (TN), CN-10395, HSDB 1119, gamma-ethyl-gamma-methyl-succinimide, Ethosuximide [USAN:INN:BAN:JAN], EINECS 201-048-7, CI 366, NSC 64013, 3-Ethyl-3-methylpyrroline-2,5-dione, CHEMBL696, .alpha.-Ethyl-.alpha.-methylsuccinimide, BRN 0117054, 3-ethyl-3-methyl-pyrrolidine-2,5-dione, CHEBI:4887, HAPOVYFOVVWLRS-UHFFFAOYSA-N, NSC64013, NSC-64013, .gamma.-Methyl-.gamma.-ethylsuccinimide, E0746, DSSTox_CID_3019, E 7138, DSSTox_RID_76832, DSSTox_GSID_23019, 2,5-Pyrrolidinedione, 3-ethyl-3-methyl-, (+-)-, Etosuximida Faes, Faes, Etosuximida, SR-01000075863, Ethosuximid, CAS-77-67-8, NCGC00016320-01, Prestwick_611, Ethosuximide [USAN:USP:INN:BAN:JAN], Spectrum_001385, AC1L1FLN, AC1Q2SOO, Prestwick0_000165, Prestwick1_000165, Prestwick2_000165, Prestwick3_000165, Spectrum2_001483, Spectrum3_000944, Spectrum4_001051, Spectrum5_001073, (.+/-.)-Ethosuximide, LAB Brand of Ethosuximide, 2, 3-ethyl-3-methyl-, D0Q4XQ, Faes Brand of Ethosuximide, NCIOpen2_000014, Pfizer Brand of Ethosuximide, Lopac0_000532, SCHEMBL34212, BSPBio_000029, KBioGR_001342, KBioSS_001865, 5-21-09-00595 (Beilstein Handbook Reference), Desitin Brand of Ethosuximide, Katwijk Brand of Ethosuximide, DivK1c_000218, SPECTRUM1502196, SPBio_001465, SPBio_001950, BPBio1_000033, GTPL7182, Jenapharm Brand of Ethosuximide, WLN: T5VMVTJ D2 D1, DTXSID7023019, Fortbenton Brand of Ethosuximide, CTK8B3160, Ethosuximide (JP15/USP/INN), Ethosuximide (JP17/USP/INN), Ethosuximide, analytical standard, HMS500K20, KBio1_000218, KBio2_001865, KBio2_004433, KBio2_007001, KBio3_002008, AOB5337, Wernigerode Brand of Ethosuximide, MolPort-003-666-417, NINDS_000218, Parke Davis Brand of Ethosuximide, United Drug Brand of Ethosuximide, gamma-Methyl-gamma-ethylsuccinimide, HMS1568B11, HMS1921L14, HMS2092D20, HMS2095B11, HMS3261L05, HMS3712B11, Pharmakon1600-01502196, HY-B1378, Ethosuximide 1.0 mg/ml in Methanol, Tox21_110370, Tox21_500532, (+/-)-2-ethyl-2-methylsuccinimide, ANW-41860, BDBM50240424, CCG-39217, MFCD00072123, NSC758192, s4626, Warner Lambert Brand of Ethosuximide, Warner-Lambert Brand of Ethosuximide, 3-ethyl-3-methylazolidine-2,5-dione, AKOS005261742, Tox21_110370_1, CS-7976, DB00593, LP00532, MCULE-4034034545, NE54559, NSC-758192, .alpha.-Methyl-.alpha.-ethylsuccinimide, IDI1_000218, 3-Ethyl-3-methyl-2, 5-pyrrolidinedion, NCGC00015418-02, NCGC00015418-03, NCGC00015418-04, NCGC00015418-05, NCGC00015418-06, NCGC00015418-08, NCGC00015418-09, NCGC00093923-01, NCGC00093923-02, NCGC00093923-03, NCGC00093923-04, NCGC00261217-01, 3-Ethyl-3-methyl-2, 5-pyrrolidinedione, AN-23917, AS-16859, SC-65415, SBI-0050515.P003, 2, 5-Pyrrolidinedione, 3-ethyl-3-methyl-, LS-147585, AB00052288, EU-0100532, FT-0668060, ST51037248, C07505, D00539, AB00052288_04, zarontin3-Ethyl-3-methyl-pyrrolidine-2,5-dione, SR-01000075863-1, SR-01000075863-3, SR-01000075863-5, W-109273, 3-Ethyl-3-methyl-pyrrolidine-2,5-dione(Ethosuximide), BRD-A99633051-001-04-7, BRD-A99633051-001-05-4, 3-Ethyl-3-methyl-pyrrolidine-2,5-dione (ethosuximide), Z2379802739, 3-ethyl-5-hydroxy-3-methyl-3,4-dihydro-2H-pyrrol-2-one, 4-ethyl-5-hydroxy-4-methyl-3,4-dihydro-2H-pyrrol-2-one, Ethosuximide, European Pharmacopoeia (EP) Reference Standard, Ethosuximide, United States Pharmacopeia (USP) Reference Standard, N-(4-fluorobenzyl)-5-hydroxy-1-methyl-2-(2-(2-methyl-1,3,4-oxadiazole-5-carboxamido)propan-2-yl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide